ID: ALA4104998

Max Phase: Preclinical

Molecular Formula: C20H24INO2

Molecular Weight: 310.42

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cc2c(cc1Oc1ccccc1)CC[N+]1(C)CCCC21.[I-]

Standard InChI:  InChI=1S/C20H24NO2.HI/c1-21-11-6-9-18(21)17-14-19(22-2)20(13-15(17)10-12-21)23-16-7-4-3-5-8-16;/h3-5,7-8,13-14,18H,6,9-12H2,1-2H3;1H/q+1;/p-1

Standard InChI Key:  VNPNCSVTUKMVBP-UHFFFAOYSA-M

Associated Targets(Human)

Neuronal acetylcholine receptor protein alpha-7 subunit 3524 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Neuronal acetylcholine receptor; alpha4/beta4 595 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Neuronal acetylcholine receptor; alpha4/beta2 3557 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Neuronal acetylcholine receptor; alpha3/beta4 1368 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Nicotinic acetylcholine receptor alpha-4/beta-2 112 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 310.42Molecular Weight (Monoisotopic): 310.1802AlogP: 4.33#Rotatable Bonds: 3
Polar Surface Area: 18.46Molecular Species: NEUTRALHBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: -0.40CX LogD: -0.40
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.79Np Likeness Score: 0.90

References

1. Crestey F, Jensen AA, Soerensen C, Magnus CB, Andreasen JT, Peters GHJ, Kristensen JL..  (2018)  Dual Nicotinic Acetylcholine Receptor α4β2 Antagonists/α7 Agonists: Synthesis, Docking Studies, and Pharmacological Evaluation of Tetrahydroisoquinolines and Tetrahydroisoquinolinium Salts.,  61  (4): [PMID:29384668] [10.1021/acs.jmedchem.7b01895]

Source